Found 0 matching trials
Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
EARLY_PHASE1The purpose of this study is to evaluate the safety and tolerability of CD1...
Location
Children's Hospital of Fudan University
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
PHASE1This is a first-in-human phase 1 study of SYNCAR-001 + STK-009 in patients ...
Status
Active Not Recruiting
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
PHASE1This is a single dose escalation study to evaluate the safety, efficacy and...
Location
Multiple Locations
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
EARLY_PHASE1This is an open-label, Phase I, investigator-initiated trial (IIT) designed...
Location
Union Hospital, Tongji Medical College, Huazhong Univerdity of Science and Technology
Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
PHASE11. Study Title:
A Study on the Efficacy and safety of Autocrine p40-Exp...
Location
Shenzhen University General Hospital
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD
PHASE1This is an open label, Multi-center,dose-escalation study in up to 18 parti...
Location
Multiple Locations
Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies
PHASE1Clinical studies of CD19 CAR-T cells in the treatment of blood and lymphati...
Location
Zhujiang Hospital of Southern Medical University
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
PHASE11. Study Title:
A Study on the Efficacy and Safety of Autocrine p40 CD1...
Location
Shenzhen University General Hospital
CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
PHASE1This is a single center, open-label ,phase 1/2 study to evaluate the safety...
Location
The First Affiliated Hospital of Soochow University
The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
NAThis is a study for patients who have been previously treated for NHL. The ...
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university